Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Entire DC Network
Intravenous Thrombolysis Before Endovascular Therapy For Large Vessel Strokes Can Lead To Significantly Higher Hospital Costs Without Improving Outcomes, Ansaar T. Rai, Sohyun Boo, Chelsea Buseman, Amelia K. Adcock, Abdul R. Tarabishy, Maurice M. Miller, Thomas D. Roberts, Jennifer R. Domico, Jeffrey S. Carpenter
Intravenous Thrombolysis Before Endovascular Therapy For Large Vessel Strokes Can Lead To Significantly Higher Hospital Costs Without Improving Outcomes, Ansaar T. Rai, Sohyun Boo, Chelsea Buseman, Amelia K. Adcock, Abdul R. Tarabishy, Maurice M. Miller, Thomas D. Roberts, Jennifer R. Domico, Jeffrey S. Carpenter
Clinical and Translational Science Institute
Background Limited efficacy of IV recombinant tissue plasminogen activator (rt-PA) for large vessel occlusions (LVO) raises doubts about its utility prior to endovascular therapy. Purpose To compare outcomes and hospital costs for anterior circulation LVOs (middle cerebral artery, internal carotid artery terminus (ICA-T)) treated with either primary endovascular therapy alone (EV-Only) or bridging therapy (IV+EV)). Methods A single-center retrospective analysis was performed. Clinical and demographic data were collected prospectively and relevant cost data were obtained for each patient in the study. Results 90 consecutive patients were divided into EV-Only (n=52) and IV+EV (n=38) groups. There was no difference in demographics, …